Are you giving men with heart failure the best care?

Abstract

Heart failure is a leading cause of morbidity and mortality worldwide. Management involves a comprehensive multidisciplinary approach focusing on symptom control, preventing disease progression and improving patients’ quality of life. Significant advances in recent years, including the introduction of combination angiotensin receptor‐neprilysin inhibitors and sodium‐glucose co‐transporter 2 inhibitors, have led to an improvement in long‐term prognosis.